Isidore Tepler
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- Hematology top 5%
- Platelet Disorders and Treatments
Papers in
- Oncology 5
- Cancer Cells and Metastasis 2
- Neutropenia and Cancer Infections 2
- Lung Cancer Research Studies 1
-
- Hematopoietic Stem Cell Transplantation 2
- Co-authors
- Paul K. Pattengale (1 shared paper)Philip Leder (1 shared paper)Eric Sinn (1 shared paper)William J. Muller (1 shared paper)Michael S. Gordon (1 shared paper)Marc B. Garnick (1 shared paper)Joseph O. Moore (1 shared paper)Bernice Kuca (1 shared paper)
- Journals
- British Journal of Haematology (1 paper)CHEST Journal (1 paper)Cell (1 paper)Psycho-Oncology (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United States
In The Last Decade
Isidore Tepler
8 papers receiving 978 citations
Isidore Tepler's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 449
- Hematology 189
- Biotechnology 98
- Genetics 259
- Immunology 185
Countries citing papers authored by Isidore Tepler
This map shows the geographic impact of Isidore Tepler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isidore Tepler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isidore Tepler more than expected).
Fields of papers citing papers by Isidore Tepler
This network shows the impact of papers produced by Isidore Tepler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isidore Tepler. The network helps show where Isidore Tepler may publish in the future.
Co-authors
The 25 scholars most cited alongside Isidore Tepler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivo Hit paper breakdown → | 1987 | 695 |
| 2 | A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. | 1996 | 252 |
| 3 | 1994 | 47 | |
| 4 | 1994 | 24 | |
| 5 | 1991 | 16 | |
| 6 | 1993 | 9 | |
| 7 | 1998 | 6 | |
| 8 | 1993 | 3 |
About Isidore Tepler
Isidore Tepler is a scholar working on Oncology, Hematology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology, having authored 8 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (2 papers), Cancer Cells and Metastasis (2 papers), Neutropenia and Cancer Infections (2 papers), Lung Cancer Research Studies (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), Immunotherapy and Immune Responses (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Oncology (449 citations), Hematology (189 citations), Biotechnology (98 citations), Genetics (259 citations) and Immunology (185 citations). Isidore Tepler has collaborated with scholars based in United States. Frequent co-authors include Paul K. Pattengale, Philip Leder, Eric Sinn, William J. Muller, Michael S. Gordon, Marc B. Garnick, Joseph O. Moore, Bernice Kuca, John W. Loewy and John W. Smith. Their work appears in journals such as British Journal of Haematology, CHEST Journal, Cell, Psycho-Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.